The Influence of Smoking Status on the Pharmacokinetics and Pharmacodynamics of Clopidogrel and Prasugrel

Platelet Reactivity After Clopidogrel Treatment Assessed With Point-of-Care Analysis and Early Drug-Eluting Stent Thrombosis

Dirk Sibbing, Siegmund Braun, Tanja Morath et al. · Journal of the American College of Cardiology · 2009 · 646 citations

Thrombopoiesis, Thrombosis, Cardiovascular Disease +10

Clopidogrel Effect on Platelet REactivity in Patients With Stent Thrombosis

Paul A. Gurbel, Kevin P. Bliden, Waiel M. Samara et al. · Journal of the American College of Cardiology · 2005 · 533 citations

Thrombopoiesis, Thrombosis, Cardiovascular Disease +8

The Association of Cigarette Smoking With Enhanced Platelet Inhibition by Clopidogrel

Kevin P. Bliden, Joseph DiChiara, Lawal Lookman et al. · Journal of the American College of Cardiology · 2008 · 223 citations

Cigarette Smoking, Thrombosis, Tobacco Control +12

Simple and reliable CYP1A2 phenotyping by the paraxanthine/caffeine ratio in plasma and in saliva

Uwe Fuhr, Karl Ludwig Rost · Pharmacogenetics · 1994 · 182 citations

Caffeine Clearance, Reliable Cyp1a2 Phenotyping, Healthy Subjects +15

Increased Active Metabolite Formation Explains the Greater Platelet Inhibition With Prasugrel Compared to High-dose Clopidogrel

Christopher D. Payne, Ying Grace Li, David S. Small et al. · Journal of Cardiovascular Pharmacology · 2007 · 167 citations